Is the Carcinoembryonic Antigen Test a Valid Predictor of Response to Medical Therapy in Disseminated Breast Cancer?
Open Access
- 1 October 1986
- journal article
- research article
- Published by SAGE Publications in Tumori Journal
- Vol. 72 (5) , 515-518
- https://doi.org/10.1177/030089168607200512
Abstract
In 30 of 63 patients with disseminated breast cancer, CEA became positive before medical therapy. Treatment response was obtained in 63.3% of CEA-positive patients compared to 15.2% of CEA-negative patients. The CEA-positive patients also had a longer relapse-free survival, a longer survival from diagnosis of metastases, and a longer overall survival from primary surgery than CEA-negative patients. CEA production appears to be an important and favorable prognostic factor in disseminated breast cancer and determinant of treatment response.This publication has 4 references indexed in Scilit:
- The Role of Carcinoembryonic Antigen in the Postmastectomy Follow-Up of Primary Breast Cancer and in the Prognostic Evaluation of Disseminated Breast CancerTumori Journal, 1984
- MATHEMATIC MODEL FOR RELATING THE DRUG SENSITIVITY OF TUMORS TO THEIR SPONTANEOUS MUTATION-RATE1979
- Clinical correlation between CEA and breast cancerCancer, 1978
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977